-
Product Insights
![]()
Tahoe Field, United States
Tahoe upstream field is located in Central Planning Area, United States. The upstream field is owned by MP Gulf of Mexico LLC (24%); W & T Energy Vi LLC (76%). It is operated by W & T Energy Vi LLC. The project started its operations in 1991. Tahoe Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Apixaban in Deep Vein Thrombosis (DVT)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Apixaban in Deep Vein Thrombosis (DVT) Drug Details: Apixaban is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GL-0034 in Obesity
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GL-0034 in Obesity Drug Details: GL-0034 is under development for the treatment of type...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MBK-001 in Non-Alcoholic Steatohepatitis (NASH)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.MBK-001 in Non-Alcoholic Steatohepatitis (NASH)Drug Details:MBK-001 is under development for the treatment of recurrent Clostridioides difficile...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Apixaban in Pulmonary Embolism
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Apixaban in Pulmonary Embolism Drug Details: Apixaban is under development for the treatment of stroke,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Apixaban in Stroke
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Apixaban in Stroke Drug Details: Apixaban is under development for the treatment of stroke, deep...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Caficrestat in Cardiomyopathy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Caficrestat in CardiomyopathyDrug Details:Caficrestat (AT-001) is under development for the treatment of diabetic complications including type...
-
Product Insights
![]()
Kila Tahoe – Tahoe City Lodge Development – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Kila Tahoe - Tahoe City Lodge Development - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
![]()
Taho Inv – 421 Northeast URBN @ Flagler – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Taho Inv - 421 Northeast URBN @ Flagler - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
Taho Inv – 401 Northeast URBN @ Flagler – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Taho Inv - 401 Northeast URBN @ Flagler - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.